Cyvek, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
7
Ending by 2030
Nov 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 17, 2027The maintenance fee for Microfluidic Assay Assemblies and Methods of Manufacture (US 10,414,143) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
- 1 fee due Jun 22, 2027The maintenance fee for Microfluidic Devices and Methods of Manufacture and Use (US 9,216,412) comes due Jun 22, 2027. Unpaid by Dec 22, 2027, it lapses early.
- 1 fee due Jul 5, 2027The maintenance fee for Method and Apparatus for Performing Assays (US 9,229,001) comes due Jul 5, 2027. Unpaid by Jan 5, 2028, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Microfluidic Assay Assemblies and Methods of Manufacture (US 11,938,710) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,700,889 | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results In force · From the USPTO record | In force | From the USPTO record | |
| US 10,076,752 | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results In force · From the USPTO record | In force | From the USPTO record | |
| US 10,209,250 | PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,414,143 | Microfluidic Assay Assemblies and Methods of Manufacture In force · Medium confidence | In force | Medium confidence | |
| US 11,292,237 | Microfluidic Assay Assemblies and Methods of Manufacture In force · Medium confidence | In force | Medium confidence | |
| US 11,938,710 | Microfluidic Assay Assemblies and Methods of Manufacture In force · Low confidence | In force | Low confidence | |
| US 9,500,645 | Micro-tube particles for microfluidic assays and methods of manufacture In force · From the USPTO record | In force | From the USPTO record | |
| US 9,546,932 | Microfluidic assay operating system and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,216,412 | Microfluidic Devices and Methods of Manufacture and Use In force · High confidence | In force | High confidence | |
| US 10,220,385 | Micro-Tube Particles for Microfluidic Assays and Methods of Manufacture In force · Medium confidence | In force | Medium confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 no status recorded